ArticleAdvances in patient-reported outcomes2025
Crosswalk between PROMIS computer adaptive tests and numerical rating scales in cancer patients: Anxiety, depression, pain interference, physical function.
Article in Advances in patient-reported outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Postexertional Symptom Exacerbation after Submaximal Exercise in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of COVID-19.Medicine and science in sports and exercise · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Aims: The study aimed to establish crosswalk between PROMIS computer adaptive tests (CATs) and numerical rating scales (NRS) in emotional distress-anxiety, emotional distress-depression, pain interference, and physical function. Methods: This retrospective analysis assessed data collected from patients from E2C2 (4/2019-1/2023), a pragmatic symptom management trial. We linked 0-10 numerical rating scales (NRS) to corresponding PROMIS CAT scores using responses within 10 min of each other and randomly selected one visit per participant. A single-group equipercentile linking method was used, with polynomial log-linear smoothing to reduce sample errors. Assumptions were tested by examining NRS-PROMIS correlations and population invariance across subgroups by sex, race, and ethnicity. Linked scores were compared with observed PROMIS scores using intraclass correlations and differences in means and standard deviations (SDs). Results: The sample sizes for the four domains ranged from 32,434 to 33,081, with 34,029 unique patients with median age 64 (range 18-102), 56 % female, 92 % white, and 1 % Hispanic. About 30 % of patients provided the highest or lowest NRS scores. The NRS and PROMIS scores were strongly correlated (0.72-0.78). Population invariance across three subgroups and four domains was supported with the standardized Root Expected Mean Square Difference (REMSD) ranging from 0.8 % to 7 % SD, which were under 8 % SD threshold. The correlations between the linked and observed T scores were high ranging from 0.73 to 0.81. All four domains had small mean differences from the observed T scores. Conclusion: This study linked the NRS and PROMIS CAT in four domains and created a crosswalk table for conversion. This study facilitates the interpretability of NRS on the metric of PROMIS CAT T-scores.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.